In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantationPanagiotis Kottaridis, Stephen Mackinnon, Ruth Pettengell et al.|Blood|2000Cited by 502
ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)Herman Waldmann, S Slavin, G Hale et al.|The Lancet|1984Cited by 424
T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapseE Naparstek, Shimon Slavin, Reuven Or et al.|British Journal of Haematology|1995Cited by 157
Systematic analysis of Fc mutations designed to enhance binding to Fc-gamma receptorsG Hale, Ian B. Wilkinson|mAbs|2024Cited by 15